tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Inhibikase Therapeutics Inc

IKT
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
2.330USD
+0.160+7.37%
์ข…๊ฐ€ย 07-23 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
307.64M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

IKT ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Inhibikase Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋А ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 12, 2026
EPS / ์˜ˆ์ƒ
-0.10/-0.11
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-0.49
57.70%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/07/23
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
37.77%-0.10
86.31%-0.10
79.63%-0.13
83.26%-0.11
79.17%-0.15
-10.81%-0.75
24.37%-0.65
40.47%-0.66
24.91%-0.73
33.37%-0.68
---0.86
---1.11
---0.98
---1.02
----
----
----
----
----
----
์ˆ˜์ต
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
์ˆœ์ด์ต
-19.75%-16.38M
-4.96%-12.73M
-106.48%-11.93M
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
์ˆœ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
-6206296.51%-417794000.00%
---5775.11%
---4963.46%
---6940.03%
---6731.67%
----
----
----
----
----
----
์ด ์ด์ต๋ฅ 
----
----
----
----
----
----
----
----
----
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
์ˆ˜์ต
----
----
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%1.00
991.33%79.57K
1676.71%116.41K
40.17%64.52K
3169.86%63.57K
-97.78%7.29K
-99.52%6.55K
-96.73%46.03K
-98.86%1.94K
771.71%328.46K
520.73%1.36M
์˜์—… ์ด์ต
-15.56%-18.22M
-1.58%-13.13M
-127.56%-13.26M
-121.57%-11.19M
-229.60%-15.76M
-193.60%-12.93M
-22.20%-5.83M
18.57%-5.05M
-1.43%-4.78M
-1.58%-4.40M
-5.67%-4.77M
-33.67%-6.20M
-1.60%-4.71M
14.01%-4.33M
-0.94%-4.51M
-76.53%-4.64M
-76.77%-4.64M
-319.83%-5.04M
-573.64%-4.47M
-534.99%-2.63M
์ˆœ์ด์ต
-19.75%-16.38M
-4.96%-12.73M
-106.48%-11.93M
-99.93%-9.92M
-194.19%-13.68M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
2.36%-4.18M
-2.24%-4.60M
-24.53%-5.78M
3.51%-4.48M
15.13%-4.28M
-0.52%-4.49M
-76.01%-4.64M
-75.98%-4.64M
-317.36%-5.04M
-566.75%-4.47M
-524.88%-2.64M
์œ ๋™์ž์‚ฐ
82.85%172.18M
82.94%180.11M
1774.34%78.54M
932.16%88.79M
771.26%94.16M
592.78%98.45M
-76.13%4.19M
-60.87%8.60M
-60.88%10.81M
-41.69%14.21M
-37.29%17.55M
-35.25%21.98M
-28.03%27.63M
-42.62%24.37M
-38.99%27.99M
-31.02%33.95M
223.38%38.39M
187.30%42.47M
153442.21%45.87M
162066.39%49.22M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-33.20%5.71M
122.33%8.30M
36.45%6.70M
137.53%8.80M
101.99%8.55M
8.58%3.73M
78.99%4.91M
35.55%3.70M
58.89%4.23M
-6.95%3.44M
-14.67%2.74M
-39.13%2.73M
-39.18%2.66M
-8.85%3.70M
18.66%3.21M
134.77%4.49M
22.06%4.38M
-14.13%4.05M
-54.22%2.71M
-58.15%1.91M
์ด ์ž์‚ฐ
83.85%173.33M
83.78%181.20M
1718.52%79.59M
906.63%88.85M
751.83%94.28M
579.69%98.60M
-75.52%4.38M
-60.50%8.83M
-60.70%11.07M
-41.83%14.51M
-37.44%17.88M
-34.26%22.35M
-26.64%28.16M
-41.28%24.94M
-37.69%28.58M
-30.93%33.99M
223.31%38.39M
187.30%42.47M
3032.69%45.87M
13323.53%49.22M
๋ถ€์ฑ„ ์ด๊ณ„
-33.20%5.71M
122.33%8.30M
36.45%6.70M
135.90%8.80M
99.25%8.55M
5.80%3.73M
71.42%4.91M
29.38%3.73M
50.98%4.29M
-9.54%3.53M
-16.90%2.86M
-35.79%2.88M
-35.11%2.84M
-3.79%3.90M
27.23%3.45M
107.74%4.49M
14.14%4.38M
-18.88%4.05M
-58.91%2.71M
-58.41%2.16M
์ž๋ณธ ์ด๊ณ„
95.52%167.62M
82.26%172.90M
13839.08%72.90M
1470.71%80.05M
1165.09%85.73M
764.16%94.87M
-103.53%-530.59K
-73.82%5.10M
-73.24%6.78M
-47.81%10.98M
-40.25%15.02M
-34.02%19.46M
-25.55%25.32M
-45.24%21.04M
-41.76%25.14M
-37.30%29.50M
323.18%34.01M
292.62%38.42M
942.17%43.16M
1074.08%47.05M
์ˆœ์˜์—…์ด์ต
-193.89%-12.06M
-40.60%-7.52M
-117.02%-10.59M
-10.29%-5.57M
-6.12%-4.10M
-55.28%-5.35M
-18.90%-4.88M
-10.71%-5.05M
35.25%-3.87M
3.20%-3.44M
25.43%-4.11M
-4.81%-4.57M
-51.80%-5.97M
13.17%-3.56M
-172.44%-5.50M
-2.57%-4.36M
0.00%-3.93M
-332.72%-4.10M
-2775.62%-2.02M
-39702.38%-4.25M
์ˆœํˆฌ์ž
-482.27%-80.48M
99.74%-98.85K
-1237.96%-28.75M
287.06%9.84M
735.73%21.05M
-1732.19%-38.76M
-85.19%2.53M
-0.26%2.54M
43.28%-3.31M
-142.63%-2.12M
181.53%17.06M
6017.70%2.55M
---5.84M
--4.96M
---20.93M
---43.09K
----
----
----
----
์ˆœ์žฌ๋ฌดํ™œ๋™
--2.90M
8.91%108.57M
-173.72%-134.13K
-99.02%31.77K
-100.00%0.00
72280.72%99.68M
259834.29%181.95K
9115.33%3.24M
-95.72%367.00K
---138.10K
--70.00
---35.99K
4289.61%8.58M
--0.00
-100.00%0.00
-100.00%0.00
50.02%-204.77K
-100.00%0.00
144.53%29.89K
781091.20%41.47M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Inhibikase Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 180.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 82.94์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 181.20M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 83.78์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 8.30M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 122.33์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 172.90M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 82.26์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -45.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -60.72์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 2.05M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 105.55์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Inhibikase Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 108.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.82์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -0.49์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 57.70์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -48.26M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -75.36์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -36.05์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 30.68์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -34.49์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 29.11์ž…๋‹ˆ๋‹ค.

Inhibikase Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Inhibikase Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -45.95M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -60.72์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ